In 2005, according to this news report, “8.8 million people became infected with tuberculosis and 1.6 million died of it. It takes months of careful antibiotic treatment to clear the infection.”
This sort of death toll is why projects like the Copenhagen Consensus, which is due for an update in 2008, cite disease control as a better way to spend a given amount of public money than many others (such as fighting global warming). It cites HIV/AIDS and malaria, though not TB, in particular.
The problem many countries — in particular developing countries like my own — face is that TB treatment is hard to enforce. Although South Africa has had some success with a buddy system to monitor drug treatment, the fact is that among poor communities, rigorous adherence to long-term drug treatments is a problem (and not only in the case of TB). Non-completion of courses of antibiotic medication leads to mutations that create drug-resistant super-strains. These affect not only the country of origin, but the rest of the world.
So, having sketched the bad news, the article cited at the top contains the good news:
Researchers have decoded the gene map of a strain of extensively drug-resistant tuberculosis and said on Tuesday their work has identified mutations that may help develop better treatments.
They also sequenced the genome of another dangerous strain called multidrug-resistant TB, as well as run-of-the-mill tuberculosis bugs, and found a few mutations may explain how the mutant strains evade antibiotics.
“By looking at the genomes of different strains, we can learn how the tuberculosis microbe outwits current drugs and how new drugs might be designed,” said Megan Murray of the Broad Institute at the Massachusetts Institute of Technology and Harvard University.
Of course, one needs to be careful with statistics such as the number of infections and deaths cited above. It turns out, for example, that statistics on HIV/AIDS have been grossly overestimated. As the Washington Post reports from Johannesburg, South Africa:
The United Nations’ top AIDS scientists plan to acknowledge this week that they have long overestimated both the size and the course of the epidemic, which they now believe has been slowing for nearly a decade, according to U.N. documents prepared for the announcement.
AIDS remains a devastating public health crisis in the most heavily affected areas of sub-Saharan Africa. But the far-reaching revisions amount to at least a partial acknowledgment of criticisms long leveled by outside researchers who disputed the U.N. portrayal of an ever-expanding global epidemic.
The latest estimates, due to be released publicly Tuesday, put the number of annual new HIV infections at 2.5 million, a cut of more than 40 percent from last year’s estimate, documents show. The worldwide total of people infected with HIV — estimated a year ago at nearly 40 million and rising — now will be reported as 33 million.
The main reason isn’t an actual decline in the underlying numbers: “U.N. officials say the revisions stemmed mainly from better measurements rather than fundamental shifts in the epidemic.”
Why is this a problem? Well, as James Taranto trenchantly notes in his Best of the Web Today column, the Washington Post piece is quite explicit about it:
Having millions fewer people with a lethal contagious disease is good news. Some researchers, however, contend that persistent overestimates in the widely quoted U.N. reports have long skewed funding decisions and obscured potential lessons about how to slow the spread of HIV. Critics have also said that U.N. officials overstated the extent of the epidemic to help gather political and financial support for combating AIDS.
“There was a tendency toward alarmism, and that fit perhaps a certain fundraising agenda,” said Helen Epstein, author of “The Invisible Cure: Africa, the West, and the Fight Against AIDS.” “I hope these new numbers will help refocus the response in a more pragmatic way.”
… Among the reasons for the overestimate is methodology; U.N. officials traditionally based their national HIV estimates on infection rates among pregnant women receiving prenatal care. As a group, such women were younger, more urban, wealthier and likely to be more sexually active than populations as a whole, according to recent studies.
The United Nations’ AIDS agency, known as UNAIDS and led by Belgian scientist Peter Piot since its founding in 1995, has been a major advocate for increasing spending to combat the epidemic. Over the past decade, global spending on AIDS has grown by a factor of 30, reaching as much as $10 billion a year.
But in its role in tracking the spread of the epidemic and recommending strategies to combat it, UNAIDS has drawn criticism in recent years from Epstein and others who have accused it of being politicized and not scientifically rigorous.
… Piot often wrote personal prefaces to those reports warning of the dangers of inaction, saying in 2006 that “the pandemic and its toll are outstripping the worst predictions.”
All of this lends support to the arguments by Taranto, Don Surber, Noel Sheppard and others, that UN claims about future dangers and funding priorities are flawed, corrupt, or both.
Large government or inter-governmental spending sprees are no match for scientific and technical progress that tackles real problems, rather than hyping up politically-correct bogeymen. Scientists outwit high powered mutants, whereas the bureaucrats create them.
But guess who’s going to get stick when a pharmaceutical company uses the excellent work of the scientists whom Eli and Edith Broad so generously fund, to make life-saving drugs for sale in Africa?